Most pharmacogenomic tests include the DPYD gene. This gene affects the ability to process certain chemotherapies that are commonly used in treating colorectal cancer, metastatic breast cancer and others.

It is estimated that about 1300 people die each year in the US because they are given 5-fluorouracil or capecitabine without being properly tested first. In the state of Missouri, this equates to ~24 unnecessary deaths each year.

If you or a loved one ever need one of these drugs, demand a pharmacogenomics test first. Better yet, get a pharmacogenomics test proactively as it can tell you about a lot of common medications proactively.

Read a short article about genetics and chemotherapy: Two patients faced chemo. The one who survived got a test to see if it was safe.

Book a 15-minute discovery call to see if pharmacogenomic testing could benefit you: https://calendly.com/genepharmer/informational-call-for-patients